PUBLISHER: Visiongain | PRODUCT CODE: 1809415
PUBLISHER: Visiongain | PRODUCT CODE: 1809415
The global Next Generation Sequencing market is projected to grow at a CAGR of 20.7% by 2035.
The Next Generation Sequencing Market Report 2025-2035 Including Impact of U.S. Trade Tariffs): This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Rising Disease Prevalence Creating Strong Demand for NGS
The increasing prevalence of complex diseases is another powerful driver for the NGS market. Rising cancer incidence, recurrent viral outbreaks, and the growing recognition of genetic disorders are all stimulating demand for advanced sequencing methods. NGS enables researchers and clinicians to decode genetic variations that underlie these diseases, supporting the development of targeted therapies and precision medicine approaches.
Rare diseases highlight this demand most clearly. More than 7,000 rare conditions affect over 30 million people in the United States alone, yet only a fraction of these diseases currently have approved treatments. This unmet need is encouraging biopharmaceutical companies to increase investment in clinical trials focused on rare conditions, with NGS playing a central role in identifying causative mutations and potential therapeutic pathways.
At the same time, emerging economies are experiencing shifts in their disease burden, moving from infectious diseases to more chronic and lifestyle-related conditions. This epidemiological transition is expanding the application of NGS to new areas of healthcare research. The growing variation in disease profiles worldwide reinforces the importance of sequencing technologies, both for addressing urgent public health challenges and for advancing long-term research into conditions that have historically been neglected.
What would be the Impact of US Trade Tariffs on the Global Next Generation Sequencing Market ?
Trade tariffs imposed by the United States have the potential to reshape the economics of the global next generation sequencing (NGS) industry. Instruments, reagents, and critical components such as flow cells and chips are often manufactured or sourced internationally, particularly from Asia. Tariffs on these imports increase procurement costs, making sequencing more expensive for academic institutions, clinical laboratories, and pharmaceutical firms. This risks slowing down clinical adoption at a time when affordability and accessibility are key to widespread uptake.
For suppliers, tariffs create pressure to reconfigure supply chains. While some US manufacturers may see short-term advantages, the market overall faces inefficiencies and rising operational costs as companies diversify sourcing or relocate production. Smaller sequencing service providers, who lack the financial resilience of larger players, may struggle to absorb these pressures, leading to greater market consolidation.
Globally, tariffs could accelerate regionalisation. Asia and Europe may push to strengthen domestic manufacturing capacity and reduce dependence on US suppliers, potentially fragmenting what has traditionally been a highly collaborative international market. In the longer term, the disruption of global supply flows and restricted access to affordable components could slow innovation cycles, with negative consequences for research and precision medicine.
What Questions Should You Ask before Buying a Market Research Report?
You need to discover how this will impact the Next Generation Sequencing market today, and over the next 10 years:
Segments Covered in the Report
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 24 leading national markets:
The report also includes profiles for 13 major companies in the Next Generation Sequencing Market, 2025 to 2035, with a focus on this segment of these companies' operations.
Overall world revenue for Next Generation Sequencing Market, 2025 to 2035 in terms of value the market will surpass US$11,530 million in 2025, our work calculates. We predict strong revenue growth through to 2035. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.